drugset / Trial / NCT04800614

A Study to Explore the Effect of Food Before a Single Dose of Sitravatinib

NCT04800614

Phase 1 Completed 36 enrolled Mirati Therapeutics Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

An Open-label, Randomized, Three-period, Crossover Study of the Effect of Food on the Pharmacokinetics of a Single Oral Dose of Sitravatinib in Healthy Adult Subjects

Timeline

Start
2021-03-15
Primary completion
2021-07-06
Completion
2022-03-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Sitravatinib Small molecule 100 mg Oral

Indications

No indication recorded.